Found 411 results
Gardner MR, Kattenhorn LM, Kondur HR, von Schaewen M, Dorfman T, Chiang JJ, Haworth KG, Decker JM, Alpert MD, Bailey CC et al..  2015.  AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges.. Nature. 519(7541):87-91.
Garces F, Lee J H, de Val N, de la Peña ATorrents, Kong L, Puchades C, Hua Y, Stanfield RL, Burton DR, Moore JP et al..  2015.  Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans.. Immunity. 43(6):1053-63.
Lee J H, Leaman DP, Kim AS, de la Peña ATorrents, Sliepen K, Yasmeen A, Derking R, Ramos A, de Taeye SW, Ozorowski G et al..  2015.  Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike.. Nat Commun. 6:8167.
Wieland A, Shashidharamurthy R, Kamphorst AO, Han J-H, Aubert RD, Choudhury BP, Stowell SR, Lee J, Punkosdy GA, Shlomchik MJ et al..  2015.  Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.. Immunity. 42(2):367-78.
Burton DR, Mascola JR.  2015.  Antibody responses to envelope glycoproteins in HIV-1 infection.. Nat Immunol. 16(6):571-6.
Lee WShi, Richard J, Lichtfuss M, Smith AB, Park J, Courter JR, Melillo BN, Sodroski JG, Kaufmann DE, Finzi A et al..  2015.  Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.. J Virol. 90(4):2021-30.
He L, Cheng Y, Kong L, Azadnia P, Giang E, Kim J, Wood MR, Wilson IA, Law M, Zhu J.  2015.  Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding.. Sci Rep. 5:12501.
Hatzi K, J Nance P, Kroenke MA, Bothwell M, Haddad EK, Melnick A, Crotty S.  2015.  BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms.. J Exp Med. 212(4):539-53.
Crotty S.  2015.  A brief history of T cell help to B cells.. Nat Rev Immunol. 15(3):185-9.
Radebe M, Gounder K, Mokgoro M, Ndhlovu ZM, Mncube Z, Mkhize L, van der Stok M, Jaggernath M, Walker BD, Ndung'u T.  2015.  Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.. AIDS. 29(1):23-33.
Richard J, Veillette M, Brassard N, Iyer SS, Roger M, Martin L, Pazgier M, Schön A, Freire E, Routy J-P et al..  2015.  CD4 mimetics sensitize HIV-1-infected cells to ADCC.. Proc Natl Acad Sci U S A. 112(20):E2687-94.
Pritchard LK, Harvey DJ, Bonomelli C, Crispin M, Doores KJ.  2015.  Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope.. J Virol. 89(17):8932-44.
Schiffner T, de Val N, Russell RA, de Taeye SW, de la Peña ATorrents, Ozorowski G, Kim HJ, Nieusma T, Brod F, Cupo A et al..  2015.  Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens.. J Virol. 90(2):813-28.
Sharma SKumar, de Val N, Bale S, Guenaga J, Tran K, Feng Y, Dubrovskaya V, Ward AB, Wyatt RT.  2015.  Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design.. Cell Rep.
Kong L, de la Peña ATorrents, Deller MC, Garces F, Sliepen K, Hua Y, Stanfield RL, Sanders RW, Wilson IA.  2015.  Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.. Acta Crystallogr D Biol Crystallogr. 71(Pt 10):2099-108.
Derking R, Ozorowski G, Sliepen K, Yasmeen A, Cupo A, Torres JL, Julien J-P, Lee J H, van Montfort T, de Taeye SW et al..  2015.  Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer.. PLoS Pathog. 11(3):e1004767.
Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, DeCamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M et al..  2015.  Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.. PLoS Comput Biol. 11(2):e1003973.
He L, Zhu J.  2015.  Computational tools for epitope vaccine design and evaluation.. Curr Opin Virol. 11:103-112.
Ingale J, Wyatt RT.  2015.  Coupling of HIV-1 gp120-derived Core Protein to Paramagnetic Beads and Adsorption Assays.. Bio Protoc. 5(20)
Kong L, Wilson IA, Kwong PD.  2015.  Crystal structure of a fully glycosylated HIV-1 gp120 core reveals a stabilizing role for the glycan at Asn262.. Proteins. 83(3):590-6.
Stanfield RL, De Castro C, Marzaioli AM, Wilson IA, Pantophlet R.  2015.  Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose.. Glycobiology. 25(4):412-9.